Research Article
Hybrid Disease Diagnosis Using Multiobjective Optimization with Evolutionary Parameter Optimization
Table 3
Signed-rank test at LOS 0.01 on resampled data.
| | Dataset | Objectives | PSVM | GSVM | FSVM | PMLP | GMLP | | value | H | value | H | value | H | value | H | value | H |
| | Cleveland | PAC | 3.69E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 8.75E−05 | 1 | 8.125E−5 | 1 | | SEN | 4.4E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 | 6.875E−5 | 1 | 1.13E−5 | 1 | | SPE | 3.69E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 8.125E−5 | 1 | 4.375E−5 | 1 |
| | Statlog | PAC | 3.69E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 | 6.11E−05 | 1 | 2.31E−05 | 1 | | SEN | 3.69E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | | SPE | 2.98E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 |
| | Spect | PAC | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 0.000963 | 1 | 5E−05 | 1 | | SEN | 4.4E−05 | 1 | 7.23E−05 | 1 | 4.4E−05 | 1 | 0.007533 | 1 | 0.009141 | 1 | | SPE | 2.98E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 |
| | Spectf | PAC | 2.98E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 5.17E−05 | 1 | 0.000726 | 1 | | SEN | 4.4E−05 | 1 | 4.4E−05 | 1 | 8.51E−05 | 1 | 0.000629 | 1 | 0.00082 | 1 | | SPE | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 2.98E−05 | 1 | 0.000627 | 1 |
| | Eric | PAC | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 0.875 | 0 | 3.69E−05 | 1 | | SEN | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 5.2E−05 | 1 | 3.69E−05 | 1 | | SPE | 3.69E−05 | 1 | 2.98E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 |
| | WBC | PAC | 4.37E−05 | 1 | 3.55E−05 | 1 | 4.37E−05 | 1 | 1 | 0 | 5E−05 | 1 | | SEN | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 0.5625 | 0 | 0.006127 | 1 | | SPE | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 0.4375 | 0 | 6.11E−05 | 1 |
| | Hepatitis | PAC | 4.4E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 0.4375 | 0 | 8.4375 | 1 | | SEN | 4.37E−05 | 1 | 5.2E−05 | 1 | 3.69E−05 | 1 | 8.75E−6 | 1 | 5.7126E−5 | 1 | | SPE | 4.4E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 1.15E−5 | 1 | 2.3123E−5 | 1 |
| | Thyroid | PAC | 4.4E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | | SEN | 4.4E−05 | 1 | 4.4E−05 | 1 | 2.98E−05 | 1 | 4.4E−05 | 1 | 2.98E−05 | 1 | | SPE | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 6.577E−5 | 1 | 0.007533 | 1 |
| | Parkinson | PAC | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 4.37E−05 | 1 | | SEN | 4.4E−05 | 1 | 2.98E−05 | 1 | 4.4E−05 | 1 | 0.006855 | 1 | 3.2366E−5 | 1 | | SPE | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 |
| | Pima Indian diabetics | PAC | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 1E−04 | 1 | | SEN | 3.69E−05 | 1 | 3.69E−05 | 1 | 2.98E−05 | 1 | 3.69E−05 | 1 | 2.98E−05 | 1 | | SPE | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 |
| | BUPA liver disease | PAC | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 3.69E−05 | 1 | | SEN | 4.4E−05 | 1 | 3.69E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | 4.4E−05 | 1 | | SPE | 3.69E−05 | 1 | 3.69E−05 | 1 | 3.69E−05 | 1 | 2.31E−05 | 1 | 2.31E−05 | 1 |
|
|
